research use only

Pravastatin HMG-CoA Reductase inhibitor

Cat.No.S5713

Pravastatin(CS-514) is a lipoprotein-lowering drug via reversibly inhibiting hydroxymethylglutaryl-CoA (HMG-CoA) reductase and the synthesis of very-low-density lipoproteins.
Jump to

Quality Control

Batch: Purity: 99.75%
99.75

Solubility

In vitro
Batch:

DMSO : 85 mg/mL (200.22 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 424.53 Formula

C23H36O7

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 81093-37-0 -- Storage of Stock Solutions

Synonyms CS-514 SMILES CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O

Read more about storage stability stock solution CAS number SMILES

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-07-24)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06912763 RECRUITING
Fibrosis Syndrome; Lymphedema; Head &Amp; Neck Cancer; Fibrosis
M.D. Anderson Cancer Center
2025-08-08 PHASE2
NCT05251129 WITHDRAWN
Vasculopathy
Montefiore Medical Center
2025-01
NCT06494111 RECRUITING
Lymphedema; Fibrosis
M.D. Anderson Cancer Center
2025-02-13 PHASE2
NCT06785727 NOT_YET_RECRUITING
Ischemic Stroke; Transient Ischemic Attack
Prof. dr. Nathalie van der Velde
2025-02-01 PHASE4
NCT07217938 RECRUITING
Radiation-associated Dysphagia; Head &Amp; Neck Cancer
Peter MacCallum Cancer Centre, Australia
2025-12-05 PHASE2
NCT06856772 NOT_YET_RECRUITING
Cardiovascular Diseases (CVD); Drug Effect; Atherosclerosis Cardiovascular Disease
Tor Biering-Sørensen
2025-02-28 PHASE4

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map